Weight Loss Jab Users Risk Regaining Most Weight After Stopping Treatment
Weight Loss Jab Users Risk Regaining Most Weight After Stopping

Weight Loss Jab Users Warned of Significant Weight Regain After Treatment Ends

Individuals using weight loss injections such as Mounjaro and Wegovy face a high risk of regaining almost two-thirds of the weight they lost within one year of discontinuing treatment, according to alarming new research from the University of Cambridge. The study, involving over 3,200 participants, found that patients typically put back on 60% of the pounds they had shed after 52 weeks.

Long-Term Implications and Health Risks

While the weight regain plateaus at approximately 75% by 60 weeks, meaning a quarter of the initial weight loss can be maintained long-term, scientists caution that if the regained weight consists primarily of fat rather than muscle, patients could end up worse off than before they started the jabs. This shift in body composition may lead to increased health risks, including metabolic issues and reduced physical fitness.

Medical student Brajan Budini explained the mechanism behind these drugs: Drugs such as Ozempic and Wegovy act like brakes on our appetite, making us feel full sooner. When people stop taking them, they are essentially taking their foot off the brake, and this can lead to rapid weight regain. These NHS-approved obesity treatments function by mimicking hormones that regulate blood sugar and appetite, originally developed for type 2 diabetes but now widely used as weight loss solutions.

Wide Pickt banner — collaborative shopping lists app for Telegram, phone mockup with grocery list

Calls for Improved Guidance and Lifestyle Changes

Experts are urging for better guidance on safely stopping these medications. Current NHS advice recommends taking semaglutide for a maximum of two years, but no such limit exists for tirzepatide, highlighting a gap in regulatory frameworks. Fellow researcher Steven Luo emphasized the importance of holistic approaches: Patients need advice on improving their diet and exercise, rather than relying solely on the drugs.

The findings underscore the necessity for comprehensive support systems, including:

  • Enhanced dietary counseling to promote sustainable eating habits.
  • Structured exercise programs to maintain muscle mass and overall health.
  • Regular medical monitoring to assess body composition changes post-treatment.

This research serves as a critical reminder that while weight loss jabs offer effective short-term solutions, long-term success depends on integrating lifestyle modifications to prevent detrimental weight regain and associated health complications.

Pickt after-article banner — collaborative shopping lists app with family illustration